Ken Shaked.jpg
​Ken Shaked 
Shaked & Co, Law Offices, Israel

Mr. Ken Shaked is the founder of Shaked & Co, Law Offices.
Mr. Shaked advises regularly his clients in all legal aspects of operations of high tech and life sciences companies, including licensing and sale of technology, joint ventures and commercial transactions.
Mr. Shaked received his LL.B from Tel Aviv University in 1988 and his MBA in 2004 from Haifa University. 
Mr. Shaked accompanied activity of commercial entities from both the business and legal aspects for more than 20 years.
Mr. Shaked worked as a lawyer at leading offices and as corporate counsel of leading companies such as EL AL and Dexxon Pharmaceutical company.
Mr. Shaked managed startup companies as a VP portfolio companies of the Hebrew University and as a CEO of startup companies in clean-tech, biotech, and medical device.


Ilan COhen.jpg

Yigal Erlich.png

Dr. Ilan Cohn

Senior Partner, Head of Department
Patent Attorney, Patents, Reinhold Cohn Group 

Dr. Ilan Cohn is one of Israel's leading experts in the field of intellectual property and has many years of experience in the field of patents and other intellectual property fields. He is a senior partner of Reinhold Cohn Group and manages the life science and chemistry department of the firm. In the course of his professional career, Ilan gained significant experience and expertise in turning intellectual property assets, particularly patents into a first tier asset. In addition to assisting entrepreneurs, investors and companies in dealing with patent matters, Ilan also advises and prepares a custom road map for building up and making use of intellectual property as strategic assets. He is involved in the establishment of intellectual property based companies in general, and in the field of life sciences, in particular, steering the build-up of the intellectual property of such companies into assets that yield profits to investors and shareholders. His experience encompasses many technology disciplines including industrial, medical, and diagnostic biotechnology, drug development, formulations, nanotechnology, chemical and biotechnological processes, natural products and extracts, and others.

He is a member of the Board of Directors of a number of several such companies and is also a member of the investment committees of venture capital funds and technological incubators.

Yigal Erlich

Founder, Chairman and Managing Partner
The Yozma Group

Mr. Yigal Erlich is the founding father of the Israeli venture capital industry.  In 1992, Mr. Erlich convinced the Israeli government to allocate $100 million Within a period of three years, established ten venture funds. These successful funds invested in more than 150 start ups and were the backbone of what is labeled today as Start UP nation. 
Between 1984 and 1992, Mr. Erlich served as the Chief Scientist of Israel's Ministry of Industry and Trade.

Mr. Erlich also started the Technology Incubator Program that led to the creation of 24 Incubation Centers throughout Israel. Mr. Erlich was instrumental in the establishment of several bi-national industrial and technology R&D cooperation agreements 
Mr. Erlich holds B.Sc. and M.Sc. in Chemistry and an MBA from the Hebrew University of Jerusalem.

David Bassa.jpg

Kfir Kachlon.jpg

Ascher Shmulewitz.png
David Bassa 
Stero Biotechs, Talent Biotechs (ex), XTL, Sela Group 

  • CEO and owner of Sela Group, a formerly traded high-tech software house with over 300 workers and 800 high tech clients.
  • Talent biotechs main shareholder (ex) – CBD for GVHD - The first Cannabis exit in Israel by selling Talent biotechs to Kalytera
  • One of the shareholders  of XTL at Nasdaq
  • Stero main shareholder - A Cannabis based startup researching CBD and Steroids synergism.  
  • Main Shareholder of additional 5 start ups in biotech or high technologies.
  • Bassa has twice won Excellence awards from the president of Israel, in 1981 and 2002.

Kfir Kachlon
Investments Principal and Cannabis-Tech Lead, Ourcrowd

Kfir Kachlon is a senior member of OurCrowd's investments team and the cannabis-technology lead at OurCrowd. 

Prior to joining OurCrowd, Kfir practiced Technology Law, focused on IP, M&As, and contracts for advanced technological projects and startups. 

Kfir earned his LL.M in International Commercial Law in 2015 from the Tel Aviv University in collaboration with UC Berkeley (Magna Cum Laude). Kfir was admitted into the Israel Bar Association in 2011. 

As an entrepreneur, Kfir founded L'etape Cycling Apparel, a consumer product company that designs, manufactures, and sells high quality and performance limited edition cycling apparel to the road cycling niche market. 

Kfir is passionate about technology and enjoys taking an active part in enabling the growth and development of technology and startup companies.

Ascher Shmulewitz
Chairman, Therapix Biosciences, Israel

Dr. Shmulewitz has more than twenty years of experience as a Life Science scientist, originator, executive, in management, operations, and finance with track record generating high multiple growth of BioPharmaceutical public and private companies in the US, Europe, and Israel. He has proven success in start-ups, turnarounds, and healthcare management, corporate and product development (in the US, Europe, and Israel as well). Dr. Shmulewitz combines extensive experience in R&D, operations, marketing, and Business Development, with start-ups and public companies.